Back
Bristol-Myers Squibb Vs. Merck & Industry Stock Comparison
Sell
45
BMY
Bristol-Myers Squibb
Last Price:
$55.84
Seasonality Move:
1.39%
Sell
27
MRK
Merck &
Last Price:
$89.50
Seasonality Move:
2.49%
Sell
45
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
-
The current Bristol-Myers Squibb [BMY] share price is $55.83. The Score for BMY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
BMY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Merck & (MRK)
is a Sell
Is Merck & a Buy, Sell or Hold?
-
MRK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $55.83Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.66 | Sell |
Relative Strength Index (14 RSI): | 45.15 | Sell |
Chaikin Money Flow: | 6790103 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.48 - 59.22) | Sell |
Bollinger Bands (100): | (53.7 - 58.62) | Sell |
MRK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.21 | Sell |
Relative Strength Index (14 RSI): | 45.2 | Sell |
Chaikin Money Flow: | 15242806 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.2 - 97.94) | Sell |
Bollinger Bands (100): | (93.39 - 107.19) | Sell |
BMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.37 | Buy |
20-day SMA: | 57.39 | Sell |
50-day SMA: | 57.07 | Sell |
200-day SMA: | 50.59 | Buy |
8-day EMA: | 55.69 | Buy |
20-day EMA: | 56.5 | Sell |
50-day EMA: | 56.73 | Sell |
200-day EMA: | 53.69 | Buy |
MRK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.71 | Buy |
20-day SMA: | 90.73 | Sell |
50-day SMA: | 96.01 | Sell |
200-day SMA: | 111.71 | Sell |
8-day EMA: | 87.05 | Buy |
20-day EMA: | 89.81 | Sell |
50-day EMA: | 94.7 | Sell |
200-day EMA: | 106.38 | Sell |
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.31 per share, an increase this year of $5.84 per share, and a decrease next year of $0.58 per share.
Merck & Earnings Growth & MRK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.11 per share, an increase this year of $1.38 per share, and an increase next year of $0.92 per share.
Bristol-Myers Squibb Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Merck & Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |